Filing Details
- Accession Number:
- 0001209191-20-002034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 17:27:49
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-06 17:27:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678223 | Neil Abdollahian | 6310 Nancy Ridge Dr Suite 101 San Diego CA 92121 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-01-03 | 2,340 | $3.42 | 51,248 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 12/31/19. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2019.
Billionaire Hedge Funds
